Capha Pharmaceuticals Inc.
FPSUF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9 | $9 | $9 | $8 |
| - Cash | $1 | $1 | $1 | $2 |
| + Debt | $560 | $489 | $416 | $338 |
| Enterprise Value | $569 | $497 | $424 | $344 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$51 | -$53 | -$58 | -$44 |
| % Margin | – | – | – | – |
| Net Income | -$71 | -$53 | -$58 | -$45 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.001 | -0.001 | -0.001 | -0.001 |
| % Growth | -37.5% | 11.1% | -28.6% | – |
| Operating Cash Flow | -$71 | -$73 | -$61 | -$47 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$71 | -$73 | -$61 | -$47 |